Exane Derivatives’s MetLife MET Stock Holding History

Exane Derivatives’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,442	Closed	-$1.09M	–	875
2022 Q1	$1.09M	Buy	15,442 +2,372	+18%	+$160K	0.31%	82
2021 Q4	$817K	Sell	13,070 -786	-6%	-$49.3K	0.2%	109
2021 Q3	$855K	Buy	13,856 +286	+2%	+$17.2K	0.21%	104
2021 Q2	$796K	Buy	13,570 +520	+4%	+$33K	0.18%	107
2021 Q1	$793K	Sell	13,050 -762	-6%	-$42.1K	0.23%	95
2020 Q4	$649K	Buy	13,812 +11,084	+406%	+$480K	0.19%	114
2020 Q3	$101K	Sell	2,728 -439	-14%	-$16.7K	0.03%	296
2020 Q2	$116K	Sell	3,167 -959	-23%	-$33.4K	0.03%	277
2020 Q1	$126K	Hold	4,126	–	–	0.04%	251
2019 Q4	$214K	Buy	4,126 +50	+1%	+$2.41K	0.04%	253
2019 Q3	$192K	Hold	4,076	–	–	0.03%	261
2019 Q2	$202K	Sell	4,076 -1,180	-22%	-$55.5K	0.04%	265
2019 Q1	$224K	Sell	5,256 -766	-13%	-$33.9K	0.04%	210
2018 Q4	$247K	Buy	6,022 +3,900	+184%	+$167K	0.04%	223
2018 Q3	$99.2K	Buy	2,122 +788	+59%	+$36K	0.02%	320
2018 Q2	$59.3K	Buy	1,334 +155	+13%	+$7.23K	0.01%	376
2018 Q1	$54K	Sell	1,179 -84	-7%	-$4.08K	0.01%	347
2017 Q4	$63.9K	Sell	1,263 -421	-25%	-$22.2K	0.01%	327
2017 Q3	$87.5K	Sell	1,684 -2,991	-64%	-$146K	0.02%	277
2017 Q2	$229K	Buy	4,675 +4,673	+233,650%	+$217K	0.05%	196
2017 Q1	$106	Hold	2	–	–	﹤0.01%	489
2016 Q4	$108	Hold	2	–	–	﹤0.01%	538
2016 Q3	$89	Sell	2 -4,521	-100%	-$170K	﹤0.01%	538
2016 Q2	$161K	Buy	+4,523	New	+$176K	0.03%	214

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Exane Derivatives's MET Position: Q2 2022 in Review

Exane Derivatives sold out of MetLife (MET) in Q2 2022, closing a stake of 15,442 shares — an estimated $1.09M sold.

Exane Derivatives first reported a position in MET in Q2 2016 and held it in 24 quarters. The position peaked at $1.09M in Q1 2022. 1,198 funds tracked by Wall St. Rank hold MET as of Q2 2022.

Exane Derivatives reported no remaining MetLife position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 15,442 MetLife shares in Q2 2022, an estimated $1.09M.
Exane Derivatives first reported a position in MetLife in Q2 2016 and held it in 24 quarters.
Exane Derivatives's MetLife position peaked at $1.09M in Q1 2022.
1,198 funds tracked by Wall St. Rank held MetLife as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.